Forward Pharma A/S
OTC: FWPAY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Claus Bo Søndergaard Svendsen
- Employees
- 4
- Headquarters
- Copenhagen, Denmark
- IPO year
- 2014
- Market cap
- $7.4M
- Website
- https://www.forward-pharma.com
Loading FWPAY…
Loading profile data…Frequently asked questions about FWPAY
What does Forward Pharma A/S (FWPAY) do?
Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both inflammatory and neurological conditions. The company was founded in 2005 and its headquarters are lo...
Where does FWPAY trade?
Forward Pharma A/S (FWPAY) trades on the Other OTC.
What sector is FWPAY in?
Forward Pharma A/S (FWPAY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Forward Pharma A/S?
Claus Bo Søndergaard Svendsen is the chief executive officer of Forward Pharma A/S (FWPAY).
Where is Forward Pharma A/S headquartered?
Forward Pharma A/S is headquartered in Denmark.
Does FWPAY pay a dividend?
Forward Pharma A/S (FWPAY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FWPAY go public?
Forward Pharma A/S (FWPAY) completed its initial public offering in 2014.